Lexicon Pharmaceuticals Inc (LXRX)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current LXRX market cap is 582M. The company's latest EPS is USD -0.4900 and P/E is -3.29.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 316k | 162k | 702k | 1.13M | 1.65M |
| Operating Income | -44.24M | -49.63M | -46.74M | -45.33M | -55.35M |
| Net Income | -44.9M | -50.53M | -49.76M | -48.4M | -53.43M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 322.07M | 24M | 298k | 139k | 1.2M |
| Operating Income | 141.45M | -180.39M | -87.09M | -100.76M | -171.75M |
| Net Income | 130.13M | -58.57M | -87.76M | -101.94M | -177.12M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 316.72M | 276.48M | 229.43M | 417.22M | 373.36M |
| Total Liabilities | 130.36M | 136.97M | 136.32M | 128.35M | 133.38M |
| Total Equity | 186.36M | 139.51M | 93.11M | 288.87M | 239.98M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 417.72M | 203.79M | 136.91M | 194.3M | 229.43M |
| Total Liabilities | 300.61M | 47.42M | 23.31M | 77.18M | 136.32M |
| Total Equity | 117.1M | 156.37M | 113.6M | 117.12M | 93.11M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -69.73M | -111.35M | -161.9M | -55.13M | -103.67M |
| Investing | -62.52M | -101.84M | -49.94M | -110.22M | -122.55M |
| Financing | 188.17M | 187.96M | 187.96M | 239.38M | 239.37M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 113.81M | -142.97M | -87.02M | -88.85M | -161.9M |
| Investing | -155.86M | 380.76M | 2.11M | -71.08M | -49.94M |
| Financing | -2.23M | -147.64M | 22.71M | 142.21M | 187.96M |
| Market Cap | 582M |
| Price to Earnings Ratio | -3.29 |
| Price to Sales Ratio | 487.88 |
| Price to Cash Ratio | 25.93 |
| Price to Book Ratio | 6.25 |
| Dividend Yield | - |
| Shares Outstanding | 361.49M |
| Average Volume (1 week) | 2.68M |
| Average Volume (1 Month) | 2.17M |
| 52 Week Change | 50.47% |
| 52 Week High | 3.73 |
| 52 Week Low | 0.92 |
| Spread (Intraday) | 0.01 (0.62%) |
| Company Name | Lexicon Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.lexpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
